United Immunity, Co., Ltd.
PrivateLast Round
VC Round
Sep 24, 2026
Total Funding Raised
$72.04M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
United Immunity, Co., Ltd. is a biotechnology company that develops nanotechnology-based immunotherapy for the treatment of cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
United Immunity, Co., Ltd. Comparables
Compare United Immunity, Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resolute Science | 83% | |
| CREATE Medicines | 82% | |
| Macrophage Therapeutics, Inc. | 82% |
United Immunity, Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 24, 2026 | ||||
| Grant | Feb 27, 2026 | ||||
| Debt | Mar 15, 2024 | ||||
| VC Round | Sep 11, 2023 | ||||
| Series B | Sep 7, 2021 | ||||
Series A Extension | Mar 31, 2021 |
Key People
Founding team and executive leadership
United Immunity, Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| Saisei Ventures | VC Round |
| Kobe University Capital | VC Round |
| Mizuho Capital | VC Round |
| UTEC (The University of Tokyo Edge Capital Partners) | VC Round |
| Joyo Bank, Ltd. | VC Round |
| 日本ベンチャーキャピタル株式会社 | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2026
$14M round led by Itochu Corporation.
- Jul 25, 2026
Monthly visitors grew 71% MoM, reaching 2.8K.
Recent news
Latest coverage and updates
- receives_financingSep 24, 2026
United Immunity Co. received financing of $13.4M in private-sector funding on Sep 24th '26.
- is_developingSep 24, 2026
United Immunity Co. is developing in vivo CAR-macrophage therapy on Sep 24th '26.
- is_developingAug 25, 2026
United Immunity Co. is developing TIM4 macrophages on Aug 25th '26.
- invests_into_assetsAug 25, 2026
United Immunity Co. invested into assets: macrophage assets in Tokyo, Japan, Eastern Asia, Asia on Aug 1st '26.
- is_developingAug 5, 2026
United Immunity Co. is developing Myeloid Targeting Platform on Aug 5th '26.
United Immunity, Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about United Immunity, Co., Ltd.'s valuation, stock price, and market status.
Is United Immunity, Co., Ltd. a public or private company?
United Immunity, Co., Ltd. is a private company.
What is the current stock price of United Immunity, Co., Ltd.?
United Immunity, Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is United Immunity, Co., Ltd. worth (valuation)?
Valuation information for United Immunity, Co., Ltd. is not publicly available.
Can I buy United Immunity, Co., Ltd. stock?
United Immunity, Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was United Immunity, Co., Ltd.'s last funding round?
United Immunity, Co., Ltd.'s most recent funding round was Grant on February 27, 2026.
Who are the main investors in United Immunity, Co., Ltd.?
Key investors in United Immunity, Co., Ltd. include Japan Agency for Medical Research and Development, Mitsubishi UFJ Capital, Axil Capital, Aozora Corporate Investment.
Will United Immunity, Co., Ltd. IPO soon?
No public IPO plans have been announced for United Immunity, Co., Ltd..
How can I track United Immunity, Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor United Immunity, Co., Ltd.'s secondary market activity and sign up for updates.